Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

Beyfortus

Biological Vaccines

NDC 49281-574-15

Open in the dashboard

General payments

$2,222,505

38,204 payments

Research payments

$0

0 payments

Through program year 2025, $2,222,505 in general payments and $0 in research payments were reported against Beyfortus (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $1,222,564 14,098
2024 General $686,345 12,461
2023 General $313,596 11,645

Breakdown

Who paid General payments · program years 2023–2025
  1. Sanofi Pasteur Inc. $2,215,268 38,193 payments
  2. Genzyme Corporation $7,025 9 payments
  3. Sanofi-Aventis U.S. LLC $213 2 payments
Top recipients General payments · program year 2025
  1. Joseph Domachowske Pediatric Infectious Diseases · Syracuse, NY $107,427 9% · 66 payments
  2. Christopher Belcher Pediatric Infectious Diseases · Carmel, IN $58,464 5% · 49 payments
  3. David Nelson Pediatrics · Washington, DC $48,463 4% · 39 payments
  4. Janak Patel Pediatric Infectious Diseases · Galveston, TX $48,136 4% · 36 payments
  5. Henry Wojtczak Pediatric Pulmonology · Albuquerque, NM $47,664 4% · 37 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatrics $488,105 42% · 4,744 practitioners
  2. Pediatric Infectious Diseases Pediatrics $279,006 24% · 21 practitioners
  3. Pediatric Pulmonology Pediatrics $101,498 9% · 14 practitioners
  4. Neonatal-Perinatal Medicine Pediatrics $47,895 4% · 90 practitioners
  5. Adolescent Medicine Pediatrics $39,012 3% · 208 practitioners

The top 5 of 113 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $174,668 14% · 1,016 recipients
  2. California $141,768 12% · 1,278 recipients
  3. New York $130,619 11% · 539 recipients
  4. Indiana $88,280 7% · 213 recipients
  5. Florida $87,478 7% · 659 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

38,204 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record